Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. is dated July 17, 2025, covering the month of July 2025. The filing serves as a supplemental submission regarding the Annual General Meeting of Shareholders scheduled for August 11, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural update and does not contain financial performance data.
Material Changes
The material change addressed in this filing is the correction of an oversight in the proxy card previously submitted on June 17, 2025. The original proxy card did not enable shareholders to vote separately for each director nominee. This filing provides an updated proxy card (Exhibit 99.1) that allows for individual voting on director nominees.
Guidance, Outlook, and Management Commentary
Management states that shareholders voting through Broadridge Financial Solutions, Inc. or the Tel Aviv Stock Exchange (TASE) should experience no issues, as these platforms already allow for individual voting regardless of the proxy card form. The re-submission is intended to ensure clarity, consistency, and good order for all shareholders. The updated proxy card is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- The Annual General Meeting is scheduled for August 11, 2025.
- An updated proxy card (Exhibit 99.1) has been issued to correct a voting mechanism error in the June 17, 2025 filing.
- Electronic voting via Broadridge or TASE remains unaffected and supports individual director voting.
- This filing contains no financial results or operational updates.